Show simple item record

Apremilast for Behcet's Syndrome - A Phase 2, Placebo-Controlled Study

dc.contributor.authorYazici, Hasan
dc.contributor.authorHatemi, Gülen
dc.contributor.authorYazici, Yusuf
dc.contributor.authorMelikoglu, Melike
dc.contributor.authorMat, Cem
dc.contributor.authorTunc, Recep
dc.contributor.authorKorkmaz, Cengiz
dc.contributor.authorOzturk, Banu Turgut
dc.contributor.authorMerkel, Peter A.
dc.contributor.authorCALAMIA, Kenneth T.
dc.contributor.authorLIU, Ziqi
dc.contributor.authorPINEDA, Lilia
dc.contributor.authorSTEVENS, Randall M.
dc.date.accessioned2021-03-05T10:20:25Z
dc.date.available2021-03-05T10:20:25Z
dc.date.issued2015
dc.identifier.citationHatemi G., Melikoglu M., Tunc R., Korkmaz C., Ozturk B. T. , Mat C., Merkel P. A. , CALAMIA K. T. , LIU Z., PINEDA L., et al., "Apremilast for Behcet's Syndrome - A Phase 2, Placebo-Controlled Study", NEW ENGLAND JOURNAL OF MEDICINE, cilt.372, ss.1510-1518, 2015
dc.identifier.issn0028-4793
dc.identifier.othervv_1032021
dc.identifier.otherav_a29bc6e9-2524-4d63-99bf-fd97b1638d72
dc.identifier.urihttp://hdl.handle.net/20.500.12627/108869
dc.identifier.urihttps://doi.org/10.1056/nejmoa1408684
dc.description.abstractBACKGROUND
dc.language.isoeng
dc.subjectTemel Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleApremilast for Behcet's Syndrome - A Phase 2, Placebo-Controlled Study
dc.typeMakale
dc.relation.journalNEW ENGLAND JOURNAL OF MEDICINE
dc.contributor.departmentSelçuk Üniversitesi , ,
dc.identifier.volume372
dc.identifier.issue16
dc.identifier.startpage1510
dc.identifier.endpage1518
dc.contributor.firstauthorID67165


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record